Physician profile
Mohammed Siddique
NPI 1871699470
$1,268.17
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $945 · 2020: $61.75 · 2021: $53.78 · 2023: $18.06 · 2024: $189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $207.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $207.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $931.19 | 2019-2020 | |
| Stryker Corporation | $147.94 | 2024 | Mako |
| Global Blood Therapeutics, INC. | $53.78 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $35.71 | 2020 | |
| Dexcom, INC. | $25.85 | 2024 | Dexcom G6 Transmitter |
| Akebia Therapeutics INC | $25.52 | 2019 | |
| Novo Nordisk INC | $18.06 | 2023 | Ozempic |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $15.37 | 2024 | Caplyta |
| Glaxosmithkline, LLC. | $14.75 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammed Siddique listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.